Business Ethics and sustainability

“Any organization that works in green activities to ensure that

all process, goods, and manufacturing processes effectively
deal with environmental issues and at the same time maintain
their profit is called sustainable business.
Pfizer have a very old commitment towards environmental
issue and health and safety issues. They are progressing on
the strength of their environmental programs to improve
sustainable practices all through their business.
Pfizer’s sustainability program is planned to make a more
integrated and tactical approach. They are setting short term
and long term priorities for environmental activities.
Waste Management and Recycling
Many different types of waste material are generated from
Pfizer’s different processes i.e. Office paper, chemicals from
laboratories, development material from manufacture, and
destruction and construction wastes when they are making
new laboratories or buildings. Pfizer has a very effective
policy to deal with the waste materials and to reuse it if
possible. They use the waste management hierarchy which
means eliminate or reduce the waste or ether reuse it or
recycle it.
They are recycling their organic solvent which they are using
in manufacturing processes. This is perhaps their major
recycled material in quantity. They are directly recycling
around 40% of solvents they are using in their operations.
They are also recovering the energy from the remaining
wastes. They also have separate dedicated containers to
collect the material which is having toxic materials i.e.
electronic equipments. This helps them in separating this
recyclable material from the other wastes.
Water usage
Protected and efficient water supply is a main challenge in
many companies. Sustainable safe water supply access is
also a main challenge. Overuse of water, and
mismanagement of water supply is also a challenge.
Although water usage in Pfizer’s laboratories and
manufacturing sites is relatively low but management of water
is very efficient.
We are striving to decrease water use, assessing our global
impact and looking for opportunities to expand our
responsibility in addressing this world health issue
`
Helping Mitigate Climate Change and Its Impacts
Climate change is one of the most critical environmental and
global health issues. Pfizer is especially concerned because
of potential impacts on world health.
We understand that as a global company, we have an
obligation to address our greenhouse gases footprint and
embrace reduction opportunities.
Pfizer has made significant progress in the performance
management of energy and greenhouse gas (GHG)
emissions from owned operations -- including measurement,
goal-setting and transparency. A variety of programs and
initiatives support our GHG reduction and Clean Energy
Goals.
To build on that foundation, we are working to address rapidly
changing legislative and stakeholder expectations and take
advantage of business-aligned opportunities. For example,
we are refining a preliminary assessment of our extended
GHG footprint. We'll use the draft World Resources Institute
and World Business Council protocol to sharpen estimates of
GHG emissions and provide meaningful feedback to both
organizations.
See our Greenhouse Gases section for details of climate
change and energy reduction efforts.
Leading Product Stewardship Efforts
Environmental impacts related to Pfizer products and
services include those within the company and activities
outside direct control — including suppliers and materials
producers, and downstream distribution, product use and
disposal. This complex value chain crosses a variety of
internal and external organizations and functions.
Stakeholders increasingly expect companies to address "life-
cycle" product impacts and embrace product design,
development and delivery opportunities to reduce those
impacts. Our Green Chemistry Program, Pharmaceuticals in
the Environment initiatives, Product Take-back pilot and
Green Packaging programs do just that. A product-focused
component of our sustainability strategy further supports
greener packaging, products and supply chain. Our global
scale positions us to be an industry leader in these areas,
and we can distinguish our products while reducing our
environmental footprint.
Sustaining Access to Potable Water
Access to clean water is one of the most important global
health issues we face today, one that may become more
critical in coming years due to our changing climate. There is
also growing consensus that sustainable access to safe water
supply will be further challenged by overuse, population
growth, economics and politics, presenting risks not only to
individuals and public sector but also to the private sector.
While Pfizer's use of water in our operations is relatively low
compared to some industries, responsible water management
is an important element of our global EHS program. We are
striving to decrease water use, assessing our global impact
and looking for opportunities to expand our responsibility in
addressing this world health issue.
Based on the association between improving world health
through sustainable access to clean water and our business
purpose as a global health care company, we are exploring
ways that Pfizer can make a difference. Initiatives for this
strategic priority include:

• Expanding our partnerships with governmental and non-

governmental organizations
• Integrating specific targets of the United Nations Millennium
Development Goals into certain business objectives
• Increasing focus on conservation measures and community
outreach efforts at locations in water-stressed or scarce areas
• Implementing additional operational controls to further
efficiencies in water recycle and reuse

Our Environmental Sustainability Focus Areas

Comprehensive assessments let Pfizer recognize
environmental efforts that are important to stakeholders and
that can drive business success. Internal interviews, external
benchmarking, best practice reviews and value proposition
evaluation led to three key strategic priorities:

• Helping mitigate climate change and its impacts

• Leading product stewardship efforts
• Sustaining access to potable water
Stakeholder Influence
Pfizer listens to a wide range of voices to understand
concerns and expectations for a global company of our scale.
We consider socially responsible investors, non-government
agencies, multilateral organizations, governments,
shareholders and the public at large. For a full picture, we
also assess public policy, UN Millennium Development Goals,
Global Reporting Initiative guidelines and media coverage.
We plan to develop and follow a comprehensive
environmental stakeholder engagement plan.
Business Drivers
To understand the potential value proposition for the
business, the comprehensive assessment included alignment
with Pfizer's Path Forward strategic priorities:

• Optimize the patent portfolio

• Find and capitalize on new opportunities for established
products
• Grow in emerging markets
• Grow our diversified businesses
• Instill a culture of innovation and continuous improvement
• Climate Change At Pfizer, we recognize that climate
change, and its potential impact on global health, is
ne f the most seriousenvironmental challenges facing
societytoday. We are committed to seizing
opportunities throughout our business to lessen our
impact and have set ambitious goals to drive our
activities. These goals and our performance are
highlighted in the performance overview at the end
of this section.
• Energy Efficiencies
By using geothermal heating and cooling buildings.
 Pfizer has made substantial efforts to reduce our
carbon and energy footprint through global
conservation and energy efficiency efforts, and
consolidation of certain operations. A wide range of
projects, such as equipment retrofits, combined heat
and power systems, and renewable energy
installations contributed to significant emissions
avoidance.
Pfizer also has a public goal to obtain 35 percent of
our electricity from clean energy sources by 2010, an
aggressive goal in this changing economic
landscape. Although we have made excellent
progress, our clean energy goal has been challenging
to attain. The current shortfall is due to a number of
factors including closure of some plants with
cogeneration capacity and the financial viability of
current clean energy technologies. Although Pfizer
will not fully achieve our goal to have 35 percent of
our electricity usage come from clean energy
sources by 2010, we remain committed to the
implementation of clean energy technologies where
it makes sound
environmental and business sense.
• Resource Conservation and
• Waste Minimization

Pfizer is committed to advancing good health in the

communities in which we operate. Our global
environment, health and safety management
program is centered on minimizing the potential
impacts of our operations as we contribute to
sustainability by reducing our emissions to the air
and water, minimizing the waste we produce, and
 improving our methods of recycling, reuse and
recovery
. Abatin g our Emissions
To help protect the Earth’s ozone layer , we are
committed to controlling and, wherever possible,
eliminating the release of harmful compounds,
including ozone depleting compounds (ODCs) and
volatile organic compounds (VOCs) from our
operations. In both cases, Pfizer set separate public
goals, and has realized significant emissions
reductions.
• Phar mace uticals in the
• Environ ment
• Trace amounts of pharmaceuticals and other organic
chemicals have been detected in the aquatic
environment.
Stakeholders are concerned that the presence of
trace amounts of medicines, known as
Pharmaceuticals in the Environment (PIE), could have
an effect on the aquatic environment and also on
human health. Pfizer recognizes our stakeholders’
concerns and has taken action. For many
years, Pfizer facilities have worked to reduce
releases of products and other materials to the
environment and
have conducted risk assessments to ensure these
releases do not have an adverse impact on public
health or the
environment. We have also participated for several
years in efforts led by pharmaceutical industry
groups to better
understand PIE and the associated risks. Through
these collaborations, we have advanced the science,
encouraged debate, and shared our knowledge with
 regulators, policy makers, and the public through
Websites like SMARXT Disposal.
However, we must do more to address stakeholder
concern. Pfizer adheres to principles of responsible
environmental
stewardship and we have increased our
commitments and stepped up initiatives to tackle the
complex issues associated with PIE.
Our strategies include:
• Continuing to engage and collaborate with the
scientific community, policy makers, regulatory
agencies, patient
groups and nongovernmental organizations
aggressively advancing the body of knowledge
related to PIE; and
• Partnering with other pharmaceutical companies
and government agencies to further explore unused
medicine disposal options, participating in product
take-back programs in countries that have initiated
them.
• Green Chemistry
Our Green Chemistry Program seeks to integrate EHS
considerations throughout the research, discovery,
development and manufacture of our products.
Green Chemistry is becoming intrinsic to the way all
Pfizer scientists and engineers perform their work—it
is about advancing scientific innovation, which lies at
the heart of our strength as a company, to reduce
our environmental footprint. Last year, notable
projects embracing Green
Chemistry principles included:
• “Naturalizing” Lyrica®—taking advantage of
nature’s own chemical catalysts (enzymes) through
biocatalysis. The enzymatic synthesis of pregabalin
 will save more than 200,000 metric tons of chemical
waste between
2007 2020.
• “Greening” Lipitor®—manufacturing atorvastatin
with a new biocatalysis process that realizes
significant energy savings by changing the
temperature at which a reaction is performed.
The Challenge

In late 2008, Pfizer began a process to refine its CSR strategy to better
support the company’s evolving business priorities and organizational
changes. This presented a new opportunity to involve senior leaders and
functions from across the company in guiding the company’s approach
to CSR. The company also wanted to leverage its strong environmental,
health, and safety (EHS) programs to build a leading environmental
sustainability initiative that would connect to and support its other CSR
strategies. Pfizer’s CSR leadership and its EHS team asked BSR to help
guide the development of these new strategies, to support their global
implementation, and to assist with its external reporting..

Our Strategy

BSR worked with Pfizer to achieve three main objectives:

1. Create a more coordinated and effective approach to CSR

management. In addition to providing ongoing, strategic guidance
to the company on how to improve global coordination of its CSR
strategy, we developed recommendations on ways to expand
board-level oversight of CSR and identify new opportunities to
involve the board in CSR strategy and decision-making. BSR also
worked to support the development of Pfizer’s global CSR
network that brings together Pfizer employees from around the
world who have CSR-related responsibilities in an effort to
localize their global CSR strategy.
2. Develop an environmental sustainability road map. BSR
partnered with Pfizer’s EHS taskforce to develop a more strategic
 approach to environmental initiatives that will result in greater
business and societal value. We began with an assessment and
benchmarking of Pfizer’s current practices by interviewing key
staff with responsibility for Pfizer’s sustainability programs. We
then led a materiality analysis and workshop with senior business
leaders to identify the environmental issues for which Pfizer could
have the biggest impact. Based on these inputs, we worked with
Pfizer to design a road map for environmental sustainability that
aims to achieve cost efficiencies, product and brand differentiation,
and, most importantly, progress on some of the world’s most
pressing environmental challenges and their impact on global
health.
3. Strengthen Pfizer’s CSR reporting. BSR also supported Pfizer’s
ongoing efforts to improve the measurement and communication
of its performance on CSR issues such as access to medicine,
research and development, patient safety, and corporate
governance. Drawing on our knowledge of best practices in
reporting, we guided the day-to-day development of Pfizer’s CSR
report, drafted the content, and identified opportunities for
innovation such as the inclusion of stakeholder voices and more
balanced commentary about challenges.

Out Impact

Our work has enabled Pfizer to make significant progress in

aligning internal CSR efforts, engaging colleagues throughout the
organization, and improving transparency.

There is now stronger board oversight and a global network of

employees who meet regularly to share approaches to managing
CSR issues in their regions. Our materiality analysis allows Pfizer
to focus its environmental sustainability strategy on three key
issues—climate, product stewardship, and water—where the
company can have the biggest potential impacts, maximizing
benefits to the environment and the company’s bottom line.
 Specific action plans and strategies for each are now being
developed.

Finally, Pfizer’s most recent CSR report has provided readers with
improved information to evaluate the company’s performance on
key issues and challenges, as well as a set of specific goals and
metrics for the year ahead. In 2010, Pfizer will begin to incorporate
CSR into the company’s annual review that accompanies its
financial report and will provide more information to all investors
about how Pfizer integrates CSR into its business practices. By
providing such information directly to all investors, the company is
signaling to the broader investment community that management
of CSR issues is a critical part of its long-term business success.

Improvement Targets
At Sandwich a key improvement Objective and Target identified through our ISO14001 programme is to improve our
general waste recycling performance. This includes a review of relevant waste streams, their segregation,
management and opportunities for increased recycling. In addition a review of performance data has been made to
establish meaningful measures that will help to demonstrate concurrent resource conservation, waste minimisation
and recycling performance.

Our drive to minimise the use of resources and maximise the recycling of our waste has included:

• A review of our general waste streams and recycling performance

• Sitewide awareness campaigns
• Additional recycling opportunities for cans and plastic bottles from site retail outlets
• A successful pilot project to remove desk side bins to encourage improved recycling and segregation using
communal office collection facilities, that resulted in a full site-wide implementation
• Recruitment of our staff as waste and recycling champions (known as Waste Beaters) to lead and promote
good recycling habits in the work place
• Incentives to use reusable mugs for beverages
• Use of napkins made from recycled materials
• Reduction in the use of unnecessary plates and other crockery enabling reduced dishwashing